These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Insulin resistance and hyperinsulinemia--clinical aspects]. Kozek E Przegl Lek; 1996; 53(9):647-52. PubMed ID: 8992530 [TBL] [Abstract][Full Text] [Related]
4. Hypertension, hyperlipidemia, insulin resistance and obesity: parts of a metabolic syndrome. Lind L; Lithell H Blood Press Suppl; 1992; 4():49-54. PubMed ID: 1345335 [No Abstract] [Full Text] [Related]
5. [Coronary risk factors. Anatomoclinical study]. Degeratu T; Nicolaescu V; Nuţă M; Cîmpeanu A; Cucu N Med Interna (Bucur); 1974 Jan; 26(1):61-72. PubMed ID: 4821152 [No Abstract] [Full Text] [Related]
6. [Primary and secondary prevention of coronary heart disease. A position paper of the International Task Force for the Prevention of Coronary Heart Disease]. Cullen P; Assmann G Dtsch Med Wochenschr; 2000 Jul; 125(28-29):881-7. PubMed ID: 10943220 [No Abstract] [Full Text] [Related]
7. [Significance of visceral fat syndrome in pathogenesis of impaired glucose tolerance]. Nakamura T Nihon Rinsho; 2005 Feb; 63 Suppl 2():246-9. PubMed ID: 15779380 [No Abstract] [Full Text] [Related]
8. Prevention of heart disease in the young coronary candidate. Kannel WB Prim Care; 1977 Jun; 4(2):229-43. PubMed ID: 586715 [TBL] [Abstract][Full Text] [Related]
9. Familial type IV hyperlipoproteinemia. Schreibman PH; Wilson DE; Arky RA N Engl J Med; 1969 Oct; 281(18):981-5. PubMed ID: 5824739 [No Abstract] [Full Text] [Related]
19. Hypertension and dyslipidemia. Jazra C J Med Liban; 2000; 48(6):364-9. PubMed ID: 11503527 [No Abstract] [Full Text] [Related]
20. Hypertension: a new perspective in therapy and metabolic effect. Part I. Medina Ruiz A Bol Asoc Med P R; 1991 Sep; 83(9):399-401. PubMed ID: 1807274 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]